| ¿µ¹® | suicide | ÇÑ±Û | ÀÚ»ì |
|---|---|---|---|
| ¼³¸í | ½º½º·Î ÀÚ½ÅÀÇ ¸ñ¼ûÀ» ²÷À½. Áï, ÇàÀ§ÀÚ°¡ ÀÚ½ÅÀÇ Á×À½À» ÃÊ·¡ÇÒ Àǵµ¸¦ °¡Áö°í ÀÚ½ÅÀÇ »ý¸íÀ» ²÷´Â ÇàÀ§. ÀÚ»ìÀÇ ¿µ¾î´ëÀÀ¾îÀÎ suicideÀÇ ¾î¿øÀº ¶óƾ¾îÀÇ sui(ÀÚ±â ÀÚ½ÅÀ»)¿Í caedo(Á×ÀÌ´Ù)ÀÇ µÎ ³¹¸»ÀÇ ÇÕ¼º¾îÀÌ´Ù. ¿©±â¼ ¾Ë ¼ö ÀÖµíÀÌ, ÀÚ»ìÀ̶õ ±× ¿øÀÎÀÌ °³ÀÎÀûÀÌµç »çȸÀûÀ̵ç, ´ç»çÀÚ°¡ ÀÚÀ¯Àǻ翡 ÀÇÇÏ¿© ÀÚ½ÅÀÇ ¸ñ¼ûÀ» ²÷´Â ÇàÀ§¸¦ ¸»ÇÑ´Ù. ÀÌ Á¤ÀÇ´Â À졧 ¸í¹éÇϱâ´Â Çϳª ½ÇÁ¦·Î´Â ¿©·¯ ¹®Á¦°¡ ÀÖ´Ù. ÀÚ»ìÀÇ ¿øÀÎÀº º¹ÀâÇÏ°í ÆÄ¾ÇÇϱ⠾î·Á¿îµ¥, Åë°è¿¡ ÀÇÇÏ¸é ½Å°æ¼è¾à-½Ç¿¬-º´°í-»ýȰ°í-°¡Á¤ºÒÈ-Àå·¡¿¡ ´ëÇÑ °í¹Î-»ç¾÷½ÇÆÐ-¿°¼¼ µî ¿©·¯ °¡Áö°¡ ÀÖÀ¸¸ç, ±× Áß¿¡¼µµ ¿°¼¼-º´°í-½Å°æ¼è¾à-½Ç¿¬-°¡Á¤ºÒȰ¡ µÎµå·¯Áö°Ô ¸¹´Ù. À̰ÍÀ» ³²³àº°·Î º¸¸é ³²ÀÚ¿¡°Ô´Â ½Å°æ¼è¾à°ú º´°í°¡ ¸¹°í, ¿©ÀÚ¿¡°Ô´Â °¡Á¤ºÒÈ¿Í ½Ç¿¬ÀÌ ¸¹´Ù. ±×¸®°í ¿¬·Éº°·Î´Â û¼Ò³â¿¡¼´Â ½Ç¿¬°ú ¿°¼¼°¡ ¸¹°í, ³ëÀο¡¼´Â º´°í°¡ Ư¡ÀûÀ¸·Î ¸¹´Ù. °¡Á¤ºÒÈ´Â 20~30´ë¿¡ ¸¹´Ù. |
||
| MSDI | Martin Suicide Depression Inventory |
|---|---|
| PAS | para aminosalicylate; Parent Attitude Scale; patient administration system; patient appointments and... |
| SA | salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame... |
| S-D | sickle-cell hemoglobin D; suicide-depression |
| SOQ | Suicide Opinion Questionnaire |
| PAS | Physician assisted suicide |
|---|---|
| ISG | IFN stimulated genes |
| mdr | Multidrug resistance genes |
| stx | Shiga toxin genes |
| or genes | gene |
| suicide | The act of killing oneself. (12 Dec 1998) |
|---|---|
| suicide, assisted | Deliberate acceleration of death of a competent patient with an incurable disease or in the extremes of suffering. The patient seeking assistance in taking his own life may ask the help of a physician or other health professional, a family member, or a friend. The milieu may be a hospital, nursing home, or private residence. Assistance to the person in dire physical or psychological distress may take the form of lethal doses of medications or chemicals to be taken orally or by injection through human intervention or with a so-called suicide machine. (12 Dec 1998) |
| suicide, attempted | The unsuccessful attempt to kill oneself. (12 Dec 1998) |
| suicide substrate | A competitive inhibitor that is converted to an irreversible inhibitor at the active site of the enzyme. Synonym: mechanism-based inhibitor. (05 Mar 2000) |
| breast cancer susceptibility genes | Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. (12 Dec 1998) |
| cancer, breast, susceptibility genes | Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. (12 Dec 1998) |
| genes | Located in the nucleus of the cell, genes contain hereditary information that is transferred from cell to cell. (09 Oct 1997) |
| genes, abl | Retrovirus-associated DNA sequences (abl) originally isolated from the abelson murine leukaemia virus (ab-mulv). The proto-oncogene abl (c-abl) codes for a protein that is a member of the tyrosine kinase family. The human c-abl gene is located at 9q34.1 on the long arm of chromosome 9. It is activated by translocation to bcr on chromosome 22 in chronic myelogenous leukaemia. (12 Dec 1998) |
| genes, apc | Tumour suppressor genes located in the 5q21 region on the long arm of chromosome 5. The mutation of these genes is associated with familial adenomatous polyposis (apc stands for adenomatous polyposis coli) and gardner's syndrome, as well as some sporadic colourectal cancers. (12 Dec 1998) |
| genes, arac | Regulatory genes which encode a cyclic AMP receptor protein required for l-arabinose utilization in e. Coli. It is an example of positive control or regulation of gene expression in the bacterial operon. (12 Dec 1998) |
| genes, archaeal | The genetic material of archaea. (12 Dec 1998) |
| genes, bacterial | The genetic material of bacteria. (12 Dec 1998) |
| genes, bcl-1 | The B-cell leukaemia/lymphoma-1 genes, associated with various neoplasms when overexpressed. Overexpression results from the t(11;14) translocation, which is characteristic of mantle zone-derived B-cell lymphomas. The human c-bcl-1 gene is located at 11q13 on the long arm of chromosome 18. (12 Dec 1998) |
| genes, bcl-2 | The B-cell leukaemia/lymphoma-2 genes, responsible for blocking apoptosis in normal cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t(14;18) translocation. The human c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18. (12 Dec 1998) |
| genes, BRCA1 | Tumour suppressor genes located on human chromosome 17q12-21. The mutation of these genes is associated with the formation of familial breast and ovarian cancer. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|